Cromos Pharma, where the patients are

United States

The Lipoprotein(a) Foundation launched

Wednesday, November 20, 2013 12:55 PM

Cardiovascular disease is the number one killer of Americans, yet 50% of hospital admissions for coronary artery disease have normal LDL-cholesterol. The Lipoprotein(a) Foundation, a nonprofit, is revealing this hidden risk for patients.

More... »

CRF Health eCOA webinar series

PharmaTimes recognizes top U.S. clinical researchers

Tuesday, November 19, 2013 01:00 PM

Winners of the U.S. Clinical Researcher of the Year competition were announced following an intense finals day hosted by partner SAS at its global headquarters in Cary, N.C.

More... »

ImmunoGen named one of The Boston Globe’s Top Places to Work

Tuesday, November 19, 2013 09:30 AM

ImmunoGen, a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, has again been named one of The Boston Globe’s Top Places to Work.

More... »

Broad Institute receives $100 million gift

Friday, November 15, 2013 01:20 PM

American philanthropists and entrepreneurs Eli and Edythe Broad are investing an additional $100 million into the Broad Instituteto launch a new decade of transformative work to harness recent biomedical discoveries to benefit patients.

More... »

Report: Biotech products in Big Pharma clinical pipelines have grown dramatically

Friday, November 15, 2013 01:18 PM

The pharmaceutical industry, especially Big Pharma, has dramatically shifted its R&D focus from its historical concentration on small molecule drugs to include a rapidly increasing number of biotechnology products, according to an analysis from the Tufts Center for the Study of Drug Development (CSDD).

More... »

Bristol-Myers Squibb Foundation awards four grants

Friday, November 15, 2013 01:13 PM

The Bristol-Myers Squibb Foundation marked World Diabetes Day and the third anniversary of its Together on Diabetes initiative by announcing four new grants focusing on the link between type 2 diabetes, depression and distress.

More... »

FDA approves Imbruvica for rare blood cancer

Wednesday, November 13, 2013 04:13 PM

The FDA has approved Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma (MCL), a rare and aggressive type of blood cancer.

More... »

AMRI announces lifting of FDA warning letter

Wednesday, November 13, 2013 09:27 AM

Albany, N.Y.-based Albany Molecular Research (AMRI) has received a close-out letter from the FDA lifting a 2010 warning letter related to its Burlington, Mass., aseptic fill-and-finish facility.

More... »

U.S. Clinical Researchers of the Year announced

Tuesday, November 12, 2013 08:00 AM

The 2013 U.S. Clinical Researchers of the Year winners have been revealed at the Umstead Hotel in North Carolina, U.S.

More... »

Genetic Alliance, PhRMA initiative for patient-focused drug development

Monday, November 11, 2013 02:56 PM

Genetic Alliance, a nonprofit health advocacy organization, and the Pharmaceutical Research and Manufacturers of America (PhRMA) announced an initiative to explore the use of a technology-enabled, crowd-sourcing approach to patient engagement as a complement to ongoing patient-focused drug development efforts under the Prescription Drug User Fee Act (PDUFA V).

More... »

CenterWatch Data Library



Browse by:


April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs